Reduced CD19+CD5+CD1d+ Bregs expression significantly in B cells of patients with MG (n = 10, 19.09 ± 2.61%) as compared to HCs (n = 10, 31.42 ± 5.55%) (P = 0.001). The gene discussed is CD19; the disease is myasthenia gravis.